# Guardian Pharmacy Services, Inc.: financial statements, quarterly

GRDN · NYSE · CIK 1802255 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/grdn.md) · [Financials](/companies/grdn/financials.md) · [Filings](/companies/grdn/filings.md) · [Insiders](/companies/grdn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/grdn/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [263](/filings/0001193125-24-256069.md) | [275](/filings/0001193125-25-117801.md) | [300](/filings/0001193125-25-177969.md) | [314](/filings/0001193125-25-274298.md) | [339 d](/filings/0001193125-26-102172.md) | [329](/filings/0001193125-26-209021.md) | [344](/filings/0001193125-26-338074.md) | [377](/filings/0001193125-25-274298.md) | [398 d](/filings/0001193125-26-102172.md) | [337](/filings/0001193125-26-209021.md) | [352](/filings/0001193125-26-338074.md) |
| Cost of revenue | $m | [211](/filings/0001193125-24-256069.md) | [220](/filings/0001193125-25-117801.md) | [239](/filings/0001193125-25-177969.md) | [254](/filings/0001193125-25-274298.md) | [271 d](/filings/0001193125-26-102172.md) | [265](/filings/0001193125-26-209021.md) | [276](/filings/0001193125-26-338074.md) | [303](/filings/0001193125-25-274298.md) | [312 d](/filings/0001193125-26-102172.md) | [260](/filings/0001193125-26-209021.md) | [272](/filings/0001193125-26-338074.md) |
| Gross profit | $m | [52.2](/filings/0001193125-24-256069.md) | [55.1](/filings/0001193125-25-117801.md) | [61.3](/filings/0001193125-25-177969.md) | [60.9](/filings/0001193125-25-274298.md) | [67.1 d](/filings/0001193125-26-102172.md) | [64.3](/filings/0001193125-26-209021.md) | [68.1](/filings/0001193125-26-338074.md) | [74.7](/filings/0001193125-25-274298.md) | [85.5 d](/filings/0001193125-26-102172.md) | [76.3](/filings/0001193125-26-209021.md) | [80.0](/filings/0001193125-26-338074.md) |
| Selling, general and administrative | $m | [58.5](/filings/0001193125-24-256069.md) | [47.2](/filings/0001193125-25-117801.md) | [44.3](/filings/0001193125-25-177969.md) | [165](/filings/0001193125-25-274298.md) | [50.3 d](/filings/0001193125-26-102172.md) | [51.3](/filings/0001193125-26-209021.md) | [55.6](/filings/0001193125-26-338074.md) | [58.4](/filings/0001193125-25-274298.md) | [54.7 d](/filings/0001193125-26-102172.md) | [58.6](/filings/0001193125-26-209021.md) | [59.4](/filings/0001193125-26-338074.md) |
| Operating income | $m | [(6.3)](/filings/0001193125-24-256069.md) | [7.9](/filings/0001193125-25-117801.md) | [17.0](/filings/0001193125-25-177969.md) | [(105)](/filings/0001193125-25-274298.md) | [16.8 d](/filings/0001193125-26-102172.md) | [13.0](/filings/0001193125-26-209021.md) | [12.6](/filings/0001193125-26-338074.md) | [16.4](/filings/0001193125-25-274298.md) | [30.8 d](/filings/0001193125-26-102172.md) | [17.7](/filings/0001193125-26-209021.md) | [20.6](/filings/0001193125-26-338074.md) |
| Interest expense | $m | [0.7](/filings/0001193125-24-256069.md) | [0.8](/filings/0001193125-25-117801.md) | [1.1](/filings/0001193125-25-177969.md) | [1.0](/filings/0001193125-25-274298.md) | [0.4 d](/filings/0001193125-26-102172.md) | [0.2](/filings/0001193125-26-209021.md) | [0.2](/filings/0001193125-26-338074.md) | [0.2](/filings/0001193125-25-274298.md) | [0.2 d](/filings/0001193125-26-102172.md) | [0.2](/filings/0001193125-26-209021.md) | [0.2](/filings/0001193125-26-338074.md) |
| Income tax | $m | not reported | [0.0](/filings/0001193125-25-117801.md) | [0.0](/filings/0001193125-25-177969.md) | [0.2](/filings/0001193125-25-274298.md) | [4.4 d](/filings/0001193125-26-102172.md) | [3.8](/filings/0001193125-26-209021.md) | [3.8](/filings/0001193125-26-338074.md) | [7.0](/filings/0001193125-25-274298.md) | [9.8 d](/filings/0001193125-26-102172.md) | [4.7](/filings/0001193125-26-209021.md) | [7.7](/filings/0001193125-26-338074.md) |
| Net income | $m | [(7.0)](/filings/0001193125-24-256069.md) | [7.1](/filings/0001193125-25-274298.md) | [0.0](/filings/0001193125-25-177969.md) | [(122)](/filings/0001193125-25-274298.md) | [11.9 d](/filings/0001193125-26-102172.md) | [9.4](/filings/0001193125-26-338074.md) | [9.0](/filings/0001193125-26-338074.md) | [9.8](/filings/0001193125-25-274298.md) | [20.9 d](/filings/0001193125-26-102172.md) | [13.3](/filings/0001193125-26-338074.md) | [21.9](/filings/0001193125-26-338074.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [0.8](/filings/0001193125-24-256069.md) | not reported | not reported | [37.2](/filings/0001193125-24-256069.md) | [4.7](/filings/0001193125-26-102172.md) | [14.0](/filings/0001193125-25-117801.md) | [18.8](/filings/0001193125-25-177969.md) | [36.5](/filings/0001193125-25-274298.md) | [65.6](/filings/0001193125-26-338074.md) | [64.9](/filings/0001193125-26-209021.md) | [89.8](/filings/0001193125-26-338074.md) |
| Current assets | $m | not reported | [130](/filings/0001193125-24-256069.md) | not reported | not reported | [180](/filings/0001193125-24-256069.md) | [152](/filings/0001193125-26-102172.md) | [166](/filings/0001193125-25-117801.md) | [170](/filings/0001193125-25-177969.md) | [198](/filings/0001193125-25-274298.md) | [222](/filings/0001193125-26-338074.md) | [235](/filings/0001193125-26-209021.md) | [255](/filings/0001193125-26-338074.md) |
| Total assets | $m | not reported | [271](/filings/0001193125-24-256069.md) | not reported | not reported | [348](/filings/0001193125-24-256069.md) | [321](/filings/0001193125-26-102172.md) | [334](/filings/0001193125-25-117801.md) | [356](/filings/0001193125-25-177969.md) | [390](/filings/0001193125-25-274298.md) | [413](/filings/0001193125-26-338074.md) | [427](/filings/0001193125-26-209021.md) | [444](/filings/0001193125-26-338074.md) |
| Current liabilities | $m | not reported | [138](/filings/0001193125-24-256069.md) | not reported | not reported | [158](/filings/0001193125-24-256069.md) | [144](/filings/0001193125-26-102172.md) | [145](/filings/0001193125-25-117801.md) | [144](/filings/0001193125-25-177969.md) | [162](/filings/0001193125-25-274298.md) | [161](/filings/0001193125-26-338074.md) | [161](/filings/0001193125-26-209021.md) | [154](/filings/0001193125-26-338074.md) |
| Total liabilities | $m | not reported | [211](/filings/0001193125-24-256069.md) | not reported | not reported | [214](/filings/0001193125-24-256069.md) | [171](/filings/0001193125-26-102172.md) | [171](/filings/0001193125-25-117801.md) | [177](/filings/0001193125-25-177969.md) | [195](/filings/0001193125-25-274298.md) | [195](/filings/0001193125-26-338074.md) | [195](/filings/0001193125-26-209021.md) | [186](/filings/0001193125-26-338074.md) |
| Long-term debt | $m | not reported | [19.0](/filings/0001193125-24-256069.md) | not reported | not reported | [28.7](/filings/0001193125-24-256069.md) | [0.0](/filings/0001193125-26-102172.md) | not reported | not reported | not reported | [0.0](/filings/0001193125-26-102172.md) | not reported | not reported |
| Shareholders' equity | $m | [59.7](/filings/0001193125-24-256069.md) | [59.9](/filings/0001193125-26-102172.md) | [56.6](/filings/0001193125-25-274298.md) | [57.2](/filings/0001193125-25-274298.md) | [134](/filings/0001193125-25-274298.md) | [150](/filings/0001193125-26-338074.md) | [163](/filings/0001193125-26-338074.md) | [180](/filings/0001193125-26-338074.md) | [195](/filings/0001193125-25-274298.md) | [218](/filings/0001193125-26-338074.md) | [232](/filings/0001193125-26-338074.md) | [258](/filings/0001193125-26-338074.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | period not labelled (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [8.7](/filings/0001193125-25-117801.md) | [29.1 d](/filings/0001193125-25-177969.md) | [(2.2) d](/filings/0001193125-25-274298.md) | [22.3 d](/filings/0001193125-26-102172.md) | [17.6](/filings/0001193125-26-209021.md) | [19.9 d](/filings/0001193125-26-338074.md) | [28.2 d](/filings/0001193125-25-274298.md) | [34.6 d](/filings/0001193125-26-102172.md) | [6.1](/filings/0001193125-26-209021.md) | [30.0 d](/filings/0001193125-26-338074.md) |
| Capital expenditure | $m | not reported | not reported | [2.2 d](/filings/0001193125-25-274298.md) | [2.3 d](/filings/0001193125-26-102172.md) | not reported | not reported | [4.0 d](/filings/0001193125-25-274298.md) | [0.5 d](/filings/0001193125-26-102172.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.